OACCU
Oaktree Acquisition Corp. III Life Sciences UnitNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
—
52W High
$11.06
52W Low
$10.31
50-Day MA
$10.71
200-Day MA
$10.72
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) is a specialized SPAC focused on merging with innovative companies in the life sciences sector. Leveraging the extensive expertise of its management team, OACCU aims to tackle critical challenges in healthcare through investments in pharmaceuticals, biotechnology, and medical technology. As the life sciences industry experiences swift transformations, OACCU is strategically positioned to create significant value for its shareholders by fostering advancements that improve patient outcomes and health management solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.37M |
| % Insiders | 3.04% |
| % Institutions | 14.90% |
Data last updated: 4/9/2026